TEGENVIST Trademark

Trademark Overview

On Tuesday, August 30, 2022, a trademark application was filed for TEGENVIST with the United States Patent and Trademark Office. The USPTO has given the TEGENVIST trademark a serial number of 97570392. The federal status of this trademark filing is REGISTERED as of Tuesday, July 22, 2025. This trademark is owned by Bayer Aktiengesellschaft. The TEGENVIST trademark is filed in the Pharmaceutical Products category with the following description:

Contrast media for use in medical imaging
tegenvist

General Information

Serial Number97570392
Word MarkTEGENVIST
Filing DateTuesday, August 30, 2022
Status700 - REGISTERED
Status DateTuesday, July 22, 2025
Registration Number7870329
Registration DateTuesday, July 22, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements

Goods and ServicesContrast media for use in medical imaging

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Thursday, June 15, 2023NON-FINAL ACTION WRITTEN
Friday, September 2, 2022NEW APPLICATION ENTERED
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 15, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023NON-FINAL ACTION E-MAILED
Thursday, June 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 12, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, November 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 25, 2024ASSIGNED TO LIE
Monday, March 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 22, 2024TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 17, 2024NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 27, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 22, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, July 22, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

tegenvist imaging medical media contrast